A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma - Top-Institutions - MDSpire

A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma

  • By

  • Zhang, Huaichao

  • Yang, Zijiang

  • Xie, Qiang

  • Chen, Pin

  • Huang, Jinlong

  • Liu, Shuang

  • Li, Zeyang

  • Sun, Wei

  • Zhang, Xiaobiao

  • Xie, Tao

  • May 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #2

    Dusseldorf Central Nervous System Tumor Tissue Bank
    Dusseldorf Central Nervous System Tumor Tissue Bank

    Düsseldorf, NRW

    Key Differentiators

    • Neuroscience
    • Oncology

  • #3

    EORTC 1419 ETERNITY study
    EORTC 1419 ETERNITY study

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Oncology

  • #4

    The Cancer Genome Atlas
    The Cancer Genome Atlas

    Bethesda, MD

    Key Differentiators

    • Genomics
    • Oncology

  • #5

    Gene Expression Omnibus
    Gene Expression Omnibus

    Bethesda, MD

    Key Differentiators

    • Genomics
    • Oncology

Original Source(s)

A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma

  • by Zhang, Huaichao , Yang, Zijiang , Xie, Qiang , Chen, Pin , Huang, Jinlong , Liu, Shuang , Li, Zeyang , Sun, Wei , Zhang, Xiaobiao , Xie, Tao

  • May 4, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate